Synthes has been growing like crazy. Mostly through acquisition of two major competitors, Stratec and Mathys medical in Europe. There is actually a hiring freeze, as management believes that the best way to control cost and show profit is to reduce hires, overhead, and development costs. This works only to some degree until the strategic requirements require further growth which can't be supported by internal infrastructure or resources. Because of this Synthes is relative slow to market with products unlike its competitors, Stryker, Zimmer and DePuy. It would be highly recommended to consider these three alternatives before you approach Synthes.